Request for Comments Regarding Foreign Nations Freeloading on American-Financed Innovation

Office of the United States Trade Representative (USTR).

Pursuant to the Executive Order titled Delivering Most-Favored-Nation Prescription Drug Pricing to American Patients, USTR invites comments from interested parties regarding any act, policy, or practice that may be unreasonable or discriminatory and that has the effect of forcing American patients to pay for a disproportionate amount of global pharmaceutical research and development, including by suppressing the price of pharmaceutical products below fair market value in foreign countries.

To be assured of consideration, please submit comments by June 27, 2025.

Submit written comments through the online USTR portal: https://comments.ustr.gov/​s/​. Follow the instructions for submission in section III below. The docket number is USTR-2025-0011. For alternatives to online submissions, please contact Catherine Gibson, Deputy Assistant U.S. Trade Representative for Monitoring and Enforcement, at [email protected] or 202.395.5725.